참고문헌
- Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009;54:2205-41. https://doi.org/10.1016/j.jacc.2009.10.015
- Mehta SR, Cannon CP, Fox KA, et al. Routine vs selective invasive strategies in patients with acute coronary syndrome: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-17. https://doi.org/10.1001/jama.293.23.2908
- Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial: randomized Intervention Trial of unstable Angina. Lancet 2002;360:743-51. https://doi.org/10.1016/S0140-6736(02)09894-X
- Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-16. https://doi.org/10.1056/NEJMoa070829
- Wang JC, Normand SL, Mauri L, Kuntz RE. Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004;110:278-84. https://doi.org/10.1161/01.CIR.0000135468.67850.F4
- Sinusas AJ, Bengel F, Nahrendorf M, et al. Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging 2008;1:244-56. https://doi.org/10.1161/CIRCIMAGING.108.824359
- Nahrendorf M, Sosnovik DE, French BA, et al. Multimodality cardiovascular molecular imaging, part II. Circ Cardiovasc Imaging 2009;2:56-70. https://doi.org/10.1161/CIRCIMAGING.108.839092
- Sanz J, Fayad ZA. Imaging of atherosclerotic cardiovascular disease. Nature 2008;451:953-7. https://doi.org/10.1038/nature06803
- Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38. https://doi.org/10.1016/j.jacc.2009.09.009
- Jaffer FA, Nahrendorf M, Sosnovik D, Kelly KA, Aikawa E, Weiss-leder R. Cellular imaging of inflammation in atherosclerosis using ma-gnetofluorescent nanomaterials. Mol Imaging 2006;5:85-92.
- Trivedi RA, Mallawarachi C, U-King-Im JM, et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006;26:1601-6. https://doi.org/10.1161/01.ATV.0000222920.59760.df
- Lee K, Moon HY, Park C, et al. Magnetic resonance imaging of ma-crophage activity in atherosclerotic plaques of apolipoprotein E-deficient mice by using polyethylene glycolated magnetic fluorescent silica-coated nanoparticles. Curr Appl Phys 2009;9:S15-8. https://doi.org/10.1016/j.cap.2008.08.040
- Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-11. https://doi.org/10.1161/01.CIR.0000020548.60110.76
- Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission to-mography. J Am Coll Cardiol 2006;48:1825-31. https://doi.org/10.1016/j.jacc.2006.03.069
- Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010;30:1282-92. https://doi.org/10.1161/ATVBAHA.108.179739
- Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47(8 Suppl):C7-12. https://doi.org/10.1016/j.jacc.2005.09.068
- Dollery CM, Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 2006;69:625-35. https://doi.org/10.1016/j.cardiores.2005.11.003
- Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664-72. https://doi.org/10.1161/01.CIR.0000087480.94275.97
- Chang K, Jaffer F. Advances in fluorescence imaging of the cardiovascular system. J Nucl Cardiol 2008;15:417-28. https://doi.org/10.1016/j.nuclcard.2008.03.001
- Jaffer FA, Vinegoni C, John MC, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 2008;118:1802-9. https://doi.org/10.1161/CIRCULATIONAHA.108.785881
- Jaffer FA, Calfon MA, Rosenthal A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol 2011;57:2516-26. https://doi.org/10.1016/j.jacc.2011.02.036
- Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010;10:36-46. https://doi.org/10.1038/nri2675
- Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 2010;107:839-50. https://doi.org/10.1161/CIRCRESAHA.110.224766
- Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011;145:341-55. https://doi.org/10.1016/j.cell.2011.04.005
- Kietselaer BL, Reutelingsperger CP, Heidendal GA, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid artery atherosclerosis. N Engl J Med 2004;350:1472-3.
- Jeziorska M, Woolley DE. Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol 1999;30:919-25. https://doi.org/10.1016/S0046-8177(99)90245-9
- Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011;32:1977-85. https://doi.org/10.1093/eurheartj/ehr054
피인용 문헌
- Nanosensors for early cancer detection and for therapeutic drug monitoring vol.10, pp.23, 2011, https://doi.org/10.2217/nnm.15.180
- Ex vivo detection of macrophages in atherosclerotic plaques using intravascular ultrasonic-photoacoustic imaging vol.62, pp.2, 2017, https://doi.org/10.1088/1361-6560/aa4f6b